Heterotypic humoral and cellular immune responses following Norwalk virus infection. - Test2 - elhamkhani - TriplyDB

Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Heterotypic humoral and cellular immune responses following Norwalk virus infection.

http://www.wikidata.org/entity/Q33614589

about

Norovirus immunity and the great escape Immunogenetic mechanisms driving norovirus GII.4 antigenic variation Critical review of norovirus surrogates in food safety research: rationale for considering volunteer studies Norovirus Advances in norovirus biology Crystal Structures of GII.10 and GII.12 Norovirus Protruding Domains in Complex with Histo-Blood Group Antigens Reveal Details for a Potential Site of Vulnerability Norovirus immunology: Of mice and mechanisms Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine Antiviral targets of human noroviruses Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.Vaccine against norovirus.Identification of cross-reactive norovirus CD4+ T cell epitopes Intranasal delivery of a bivalent norovirus vaccine formulated in an in situ gelling dry powder.Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.Noroviruses - State of the Art.Serological correlate of protection against norovirus-induced gastroenteritis Susceptibility to winter vomiting disease: a sweet matter.Norovirus GII.4 strain antigenic variation Chimpanzees as an animal model for human norovirus infection and vaccine development.Vitamin A modifies the intestinal chemokine and cytokine responses to norovirus infection in Mexican children Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice Isolation of cross-reactive human monoclonal antibodies that prevent binding of human noroviruses to histo-blood group antigens.Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity Characterization of emerging GII.g/GII.12 noroviruses from a gastroenteritis outbreak in the United States in 2010 Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial Norovirus infectivity in humans and persistence in water Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus.Virus Genotype Distribution and Virus Burden in Children and Adults Hospitalized for Norovirus Gastroenteritis, 2012-2014, Hong Kong.Serum Immunoglobulin A Cross-Strain Blockade of Human Noroviruses Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.Application of salivary antibody immunoassays for the detection of incident infections with Norwalk virus in a group of volunteers.Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus.Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses Norovirus vaccine development: next steps.Norovirus vaccines: Correlates of protection, challenges and limitations Norovirus vaccine against experimental human Norwalk Virus illness.

P2860

Q21090486-B2242471-96D9-447C-B7AF-101594982E6A Q24810360-95AAF9D0-FE23-4D8D-B1C0-DE761E7A9A76 Q26853341-807AFF23-E426-4FC3-BE6E-05F2F10FDA7E Q26864280-066F20C6-D2DB-4156-B627-83F294D42469 Q27016152-03E18AB6-EE21-4005-8A5B-1ABBD0778586 Q27667594-A8DF4B79-3170-4707-9512-C5DEB7640E4D Q28083087-62DEEC43-FA3A-4D99-9DBD-2B3D7BCB65A1 Q28728786-56D46D4B-F439-4B8B-AE5E-2F4A41F3B28B Q30249527-A8A8284F-1F36-42CC-83EC-841A63C7F5E8 Q30409563-0C634CD5-9F67-407F-8F37-B2740FDC7B45 Q30425145-4159AC18-BF42-496D-8614-44D286669E08 Q33578075-58DB8876-DFEA-4856-BA71-F8424D220066 Q33614545-D1116377-2C67-4712-B2C1-A4D777A3ED5E Q33703664-B6814EB2-7B2A-4B26-AD47-B5E94F75D8FB Q33743992-703CC1E9-4530-4513-BB49-68AB7204DF3D Q34059136-8A8A9B3C-D26E-47B7-A898-42D4217A789C Q34090629-182C91DD-23AD-454C-99C2-779E4C67C497 Q34153875-EF4395B5-DFF7-430B-A8CD-323443BD6053 Q34227237-F044D787-A337-4976-B765-5FABE91C2ADE Q34457831-897ED977-B82A-433C-9673-22E34FB96BAC Q34471908-E0C8A0B0-6C87-44CC-9FA4-3CA45E8DA1B9 Q34802923-CDAE5722-F030-466C-930D-0CC1146E1267 Q34907018-338B6E63-97B2-4834-8ED9-A401CC5F27EE Q34985473-230A1021-A09D-4940-9227-E3462685691B Q35021149-436D01E1-BD26-497D-9D61-CBBCCF81CB3C Q35192204-4171B82F-B8F9-45C6-A0B8-03351F0A6912 Q35212408-784EB737-0C45-4FDB-9E46-7F256EDD5D10 Q35271689-7E6C31D0-D89A-49A7-9AE6-058D0C5CAA05 Q35656636-52A0A634-BE1F-484F-8271-6C5E1DFB86B6 Q35739052-59DFF109-8CA6-44D9-BD16-F044FD6AED09 Q35749942-C4BEB75C-EBD4-439C-BEE2-3CEDC2ABE536 Q35837799-2F6E37C9-0E0C-4ADE-8ACA-0B69189DFF37 Q36275589-4BBAD2A0-5072-40DD-989E-9800AAD70E87 Q36414470-4684CCBA-9F51-4C1F-A9BA-009712D1DDB3 Q36490501-C7218B2A-5376-474E-821D-EC240DDAF346 Q36505171-F113372C-8FBF-4414-B6BD-9CE2FF7D3E83 Q36911792-D7926E35-7E15-4876-AE98-4D26CCD81861 Q37133116-D65A7340-6423-45D1-ABA3-883CD8CC5C65 Q37135476-4ACDFDA8-EB09-4546-811B-83207218CF14 Q37144052-EF484C57-38E6-4AE1-8551-078A42D1FED5

P2860

Heterotypic humoral and cellular immune responses following Norwalk virus infection.

http://www.wikidata.org/entity/Q33614589

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Heterotypic humoral and cellular immune responses following Norwalk virus infection.

@ast

Heterotypic humoral and cellular immune responses following Norwalk virus infection.

@en

type

label

Heterotypic humoral and cellular immune responses following Norwalk virus infection.

@ast

Heterotypic humoral and cellular immune responses following Norwalk virus infection.

@en

prefLabel

Heterotypic humoral and cellular immune responses following Norwalk virus infection.

@ast

Heterotypic humoral and cellular immune responses following Norwalk virus infection.

@en

P1433

Q33614589-EE5F7882-F648-4BB9-9847-4BFB34488C3D

P1476

Q33614589-DED81C2A-BED0-42FC-BEE7-730A0BAAB890

P2093

Q33614589-224D3DA1-11A1-4ACD-B11B-DAB888FBEF05

Q33614589-35A91B95-2F30-4AE7-A8C8-B6E193463783

Q33614589-3D6EA56D-4ACA-4308-BB7B-BF87E14206C6

Q33614589-43C0EB66-6F40-4545-A092-F6227548AA7C

Q33614589-4878D540-D28E-4335-9CDA-A42082853149

Q33614589-98185CF7-307D-4240-9883-E508509B196E

Q33614589-D5C64D67-7593-4C84-8ECA-2FDC07D1C79A

P2860

Q33614589-03117D98-AB46-4D3A-B95E-DDD01348D755

Q33614589-07030264-C4AF-4928-A779-9BB79B1A1169

Q33614589-085E86EF-5306-4ED8-8DBA-4DDC2EC5D4C6

Q33614589-09582638-4CC7-482C-95DB-229D96EEC7C9

Q33614589-0EA09293-8993-4DB8-A8C5-394C231444F5

Q33614589-0F187935-470D-4953-86DC-74E961283A01

Q33614589-0F1B6151-8A5A-4F0E-96D1-C18F8BB07197

Q33614589-0FD4DE6D-BB95-45BD-A501-B24DFA1BDE1B

Q33614589-12F294B7-018F-446C-A25A-FA1160877FB0

Q33614589-131B85DD-8951-492B-974B-B9A40D586C3C

P304

Q33614589-B4177A04-25CB-4D15-B346-AA2A144D7871

P31

Q33614589-BB44F531-FD3E-4DCB-9CED-2B5F1B145E96

P356

Q33614589-BDC9CD4A-8930-4D76-BC0E-8A68D32BF963

P433

Q33614589-7EECB226-C3F5-4C43-86BF-4DE9148E88D2

P478

Q33614589-59AC77AE-A1F2-411A-95F7-7B60AA0C5851

P50

Q33614589-1F0058AE-1041-4061-A45C-DFBB95528DEA

P577

Q33614589-1DB1D673-91BC-4862-A1F6-503553E93567

P698

Q33614589-C2A96D14-A50D-4A3B-9FA1-2F7B456771A7

P921

Q33614589-40429DF0-57C7-452C-B22F-6521A27C1484

P932

Q33614589-998FE952-7216-4ED6-980B-FC903F820B2E

P356

P1433

Journal of Virology

P1476

Heterotypic humoral and cellular immune responses following Norwalk virus infection.

@en

P2093

Christine L Moe

http://www.w3.org/2001/XMLSchema#string

David J Weber

http://www.w3.org/2001/XMLSchema#string

Eric Donaldson

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Frelinger

http://www.w3.org/2001/XMLSchema#string

Juan Leon

http://www.w3.org/2001/XMLSchema#string

Lisa C Lindesmith

http://www.w3.org/2001/XMLSchema#string

Robert E Johnston

http://www.w3.org/2001/XMLSchema#string

P2860

Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution

A homozygous nonsense mutation (428G-->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections

Cellular and humoral immunity following Snow Mountain virus challenge

The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors

Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

Multiple sequence alignment with the Clustal series of programs

Structural basis for the recognition of blood group trisaccharides by norovirus

ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures

MrBayes 3: Bayesian phylogenetic inference under mixed models

X-ray crystallographic structure of the Norwalk virus capsid

P304

1800-1815

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02179-09

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20007270

http://www.w3.org/2001/XMLSchema#string

P921

P932

2812379

http://www.w3.org/2001/XMLSchema#string